Risperidone News
Drug Continuity May Aid In Better Treatment Outcomes
Switching antipsychotic medications may come at a cost, suggests a new analysis of CATIE data, so prescribers should optimize medication regimens before considering a switch.
Older schizophrenia drug works, costs less: Study
A new study finds that an older antipsychotic drug is cheaper and equally effective for some patients with schizophrenia, sending makers of newer drugs scrambling to defend their products on Friday.
Generic Competition to End the Robust Growth of the Schizophrenia Drug Market
Atypical Antipsychotic Sales will Decrease from $5.4 Billion in 2005 to $4.8 Billion in 2015. AstraZeneca/Targacept's Ispronicline Will Be the First Available Agent to Treat the Cognitive Symptoms of Schizophrenia, According to a...
U.S. District Court Upholds RISPERDAL(R) Patent
Janssen, L.P. today announced that a U.S. District Court upheld the validity and enforceability of the RISPERDAL® (risperidone) patent. The injunction that was entered prohibits Mylan Pharmaceuticals, Inc. and Dr. Reddy's...
Risperdal Approved for Autism Symptoms in Children
The adult antipsychotic drug Risperdal (risperidone) has been approved by the U.S. Food and Drug Administration to treat behaviors associated with autism in children and adolescents.